RVPH Reviva Pharmaceuticals Holdings Inc.
2,650
$3.68
$0.15
(3.92%)
| Market Cap | $102.74M |
| Volume (M) | 551,746.00 |
| 52-Wk High | $9.25 |
| 52-Wk Low | $3.03 |
ST Data
Watchers
New Watcher Rank
Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor ConferenceGlobe Newswire • 7 days ago
CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...
Share to Feed
CUPERTINO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...
Key Insights Significant control over Reviva Pharmaceuticals Holdings by retail investors implies that the general...
CUPERTINO, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...
Brilaroxazine's Positive Trial Outcomes Amidst Increased Net LossRelated Stocks: RVPH...
- RECOVER global Phase 3 trial successfully met all primary and secondary endpoints with statistically significant and clinically meaningful reductions across all major symptom domains at week 4 with...
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH Free Report) Analysts at HC Wainwright boosted their Q4 2023 EPS estimates for Reviva Pharmaceuticals in a report released on...
- Successfully met primary endpoint; brilaroxazine 50 mg delivered a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale (PANSS) total...
In trading on Monday, drugs shares were relative leaders, up on the day by about 2.5%. Leading the group were shares of Reviva Pharmaceuticals Holdings, up about 64.9% and shares of Deciphera...
This is a signal that RVPH's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
Latest RVPH News
Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Globe Newswire • 7 days ago
Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Globe Newswire • 17 days ago
Retail investors among Reviva Pharmaceuticals Holdings, Inc.'s (NASDAQ:RVPH) largest stockholders and were hit after last week's 34% price drop
Simply Wall St • 17 days ago